Lee L - Search Results

1

Determination of Vatiquinone Drug-Drug Interactions, as CYP450 Perpetrator and Victim, Using Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation.

Lee L, Okudaira N, Murase K, Kong R, Jones HM. Lee L, et al. J Clin Pharmacol. 2024 Sep 23. doi: 10.1002/jcph.6133. Online ahead of print. J Clin Pharmacol. 2024. PMID: 39308341

2

Clinical Drug-Drug Interaction Between Vatiquinone, a 15-Lipoxygenase Inhibitor, and Rosuvastatin, a Breast Cancer Resistance Protein Substrate.

Lee L, Murase K, Ma J, Thoolen M. Lee L, et al. Clin Pharmacol Drug Dev. 2023 Mar;12(3):279-286. doi: 10.1002/cpdd.1199. Epub 2022 Dec 7. Clin Pharmacol Drug Dev. 2023. PMID: 36478438

3

A pharmacokinetic drug-drug interaction study between rosuvastatin and emvododstat, a potent anti-SARS-CoV-2 (COVID-19) DHODH (dihydroorotate dehydrogenase) inhibitor.

Morton TL, Laskin OL, Kaushik D, Lee L, Ma J, Kristensen A, O'Keefe K, Golden L, Klein M, Kong R. Morton TL, et al. Among authors: lee l. Pharmacol Res Perspect. 2023 Apr;11(2):e01076. doi: 10.1002/prp2.1076. Pharmacol Res Perspect. 2023. PMID: 36938928 Free PMC article.

4

Absorption, distribution, metabolism and excretion of ¹⁴C-vatiquinone in rats, dogs, and human subjects.

Ma J, Lee L, Yao B, Giannousis P, Thoolen M, Ye Q, Golden L, Klein M, Kong R. Ma J, et al. Among authors: lee l. Xenobiotica. 2023 May;53(5):396-411. doi: 10.1080/00498254.2023.2245459. Epub 2023 Aug 18. Xenobiotica. 2023. PMID: 37552765 Free article.

5

Lack of Concentration-QTc Relationship and Cardiac Risk With Vatiquinone Therapeutic and Supratherapeutic Doses.

Lee L, Flach S, Xue H, Arivelu L, Golden L, Kong R, Darpo B. Lee L, et al. Clin Pharmacol Drug Dev. 2024 Nov;13(11):1227-1238. doi: 10.1002/cpdd.1476. Epub 2024 Oct 17. Clin Pharmacol Drug Dev. 2024. PMID: 39415654 Clinical Trial.

6

Bridging the Gap With Clinical Pharmacology in Innovative Rare Disease Treatment Modalities: Targeting DNA to RNA to Protein.

Lee L, Gollen R, Fathallah AM, Gao L, Patil S. Lee L, et al. J Clin Pharmacol. 2022 Dec;62 Suppl 2:S95-S109. doi: 10.1002/jcph.2172. J Clin Pharmacol. 2022. PMID: 36461740 Review.

7

Natural History and Real-World Data in Rare Diseases: Applications, Limitations, and Future Perspectives.

Liu J, Barrett JS, Leonardi ET, Lee L, Roychoudhury S, Chen Y, Trifillis P. Liu J, et al. Among authors: lee l. J Clin Pharmacol. 2022 Dec;62 Suppl 2(Suppl 2):S38-S55. doi: 10.1002/jcph.2134. J Clin Pharmacol. 2022. PMID: 36461748 Free PMC article. Review.

8

A Streamlined Approach to Anticounterfeiting Technologies: Patterned AAO Membranes Based on Photonic Crystal Effects with Tunable Color Shifts and pH Responsiveness.

Lin YC, Lee LR, Tsai TH, Lin J, Hsu YS, Kesavan M, Lin YL, Chen YF, Chen JT. Lin YC, et al. Among authors: lee lr. Small. 2025 Jan 14:e2409919. doi: 10.1002/smll.202409919. Online ahead of print. Small. 2025. PMID: 39807677

9

The impact of resident involvement and postgraduate year on head and neck surgery for obstructive sleep apnea.

Bentan MA, Mastoloni E, Lee L, Nord R. Bentan MA, et al. Among authors: lee l. PLoS One. 2025 Jan 13;20(1):e0317381. doi: 10.1371/journal.pone.0317381. eCollection 2025. PLoS One. 2025. PMID: 39804892 Free article.

10

Characterization of the immune cell profile in metastatic nasopharyngeal carcinoma treated with chemotherapy and immune checkpoint inhibitors.

Kuo YC, Tai TS, Yang HY, Lui KW, Chao YK, Lee LY, Huang Y, Fan HC, Lin AC, Hsieh CH, Yang Z, Chang KP, Lin CY, Wang HM, Hsu CL. Kuo YC, et al. Among authors: lee ly. Am J Cancer Res. 2024 Dec 15;14(12):5717-5733. doi: 10.62347/SSPI9013. eCollection 2024. Am J Cancer Res. 2024. PMID: 39803661 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,328 results

Search Page

Filters